Janus Henderson Group PLC Cara Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $92,538 - $232,197	18,924 New	18,924 $92,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $2.11 Million - $4.98 Million	-170,475 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $2.57 Million - $3.7 Million	170,475 New	170,475 $3.7 Million

12.7M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $260M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.